Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
We review which stablecoins fall under regulatory scrutiny, the regimes that apply, and practical implications for users and providers alike.
19,522 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Public scrutiny can spill over into family finances. This article examines Gary Coleman’s ex-wife faces renewed quest...
MP Materials is catching investor attention again in 2026 as policy support, domestic production efforts, and a risin...
Girls Who Code CEO Tarika Barrett says 70% of teen girls want cybersecurity careers, but a weak pipeline threatens a ...
Retirees chasing amlp’s 7.9% yield face a tug-of-war between high income and the risk of payout gaps. This deep dive ...
Arm Holdings has surged this year on AI infrastructure bets, but a breather may be near as the company shows solid ea...
Investors often ask where will stock years? BYD’s five-year path holds both promise and risk. This guide breaks down ...
A federal judge granted preliminary approval to a group of tuccori opt-in settlements preliminary totaling $106 milli...
When A-list stars team up with fearless style, it’s not just a mood board moment. It’s a finance lesson in branding, ...
Florida’s housing market finds footing in late May 2026 as pending sales rise and inventory stabilizes. Sellers face ...
Vitalik Buterin’s call for local AI hosting has sparked debate over practical limits and the role of cloud providers ...
A clear spark lit up Rivian stock as the R2 SUV launch was confirmed. This piece breaks down what it means for the st...